Top Story

Researchers identify risk factors for development of pancreatic cancer

April 27, 2015

A team of international researchers developed a profile identifying risk factors for malignancy progression in intraductal papillary mucinous neoplasms of the pancreas.

“The factors we found that increase risk of pancreatic cancer now allow us to separate patients as either low or high risk. High-risk patients can then be scanned and biopsied more frequently or can opt for surgery, but low-risk patients don’t need such surveillance,” Michael B. Wallace, MD, MPH, from Mayo Clinic in Jacksonville, Fla., said in a press release. “Pancreatic cancer is difficult to detect early — most patients are diagnosed at later stages when it’s 95% fatal — so we’re seeking ways to understand who is at risk.”

In the Journals

Hodgkin’s lymphoma survivors face high risk for cardiovascular diseases

April 27, 2015
Survivors of Hodgkin’s lymphoma who were treated during adolescence or adulthood faced a high lifetime risk for cardiovascular events, according to study…
In the Journals

Three-year postoperative surveillance cost-effective for patients with low-risk papillary thyroid cancer

April 27, 2015
Compared with annual surveillance, postoperative surveillance every 3 years, after 5 years of annual surveillance is projected to be cost-effective in patients with…
Meeting News Coverage

Top 5 lessons learned at SGO's Women's Cancer Annual Meeting

April 27, 2015
Surgical and medical approaches to ovarian cancer, sentinel node mapping for endometrial cancer, the use of tissue morcellation for uterine tissue extraction, and the…
Health Care Legislative and Regulatory Update

Act III for meaningful use — The EHR incentive program Stage 3 proposed rule

April 27, 2015
CMS issued its Stage 3 Meaningful Use Proposed Rule on March 30 (Proposed Rule). Stage 3 is expected to be the final stage of the Electronic Health Record (EHR)…
More News Headlines »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

April 26, 2015
NEW YORK — Sanjiv S. Agarwala, MD, professor of medicine at Temple University School of Medicine, chief of…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan